VAERS Explorer
Back to explore

Report #2838158

Received Apr 26, 2025

Disabled
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
78 yrs
State
ME
Recovered
Unknown
Vaccinated
Dec 1, 2023
Onset
Jan 1, 2024
Days to onset
31
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALS13X325IM

Symptoms (4)

Giant cell arteritisHeadacheMalaiseVisual impairment

Symptom narrative

Patient felt unwell after the vaccine with intermittent headaches and ultimately was diagnosed with giant cell arteritis with partial vision loss in 8/2024. She was treated with high dose prednisone and one infusion of Actemra. She is currently tapering her prednisone still. She has persistent vision loss but has not had new loss of vision.